Here are the latest quarterly results of BALAXI PHARMA. For more details, see the BALAXI PHARMA financial fact sheet and BALAXI PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-22* |
3
Jun-22* |
3
Sep-22* |
3
Dec-22* |
3
Mar-23* |
3
Jun-23* |
3
Sep-23* |
3
Dec-23* |
8-Qtr Chart Click to enlarge |
|
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | Rs m | 891 | 828 | 864 | 866 | 807 | 660 | 547 | 608 | |
Other income | Rs m | 41 | 33 | 41 | -46 | -2 | -10 | 3 | -1 | |
Turnover | Rs m | 932 | 861 | 905 | 820 | 805 | 649 | 550 | 607 | |
Expenses | Rs m | 779 | 690 | 716 | 713 | 679 | 571 | 440 | 471 | |
Gross profit | Rs m | 112 | 137 | 148 | 153 | 127 | -378 | 164 | 153 | |
Depreciation | Rs m | 2 | 2 | 2 | 2 | 12 | 3 | 7 | 5 | |
Interest | Rs m | 1 | 2 | 0 | 0 | 3 | 3 | 4 | 4 | |
Profit before tax | Rs m | 150 | 166 | 187 | 105 | 111 | -394 | 157 | 143 | |
Tax | Rs m | 23 | 25 | 32 | 23 | 30 | 19 | 12 | 7 | |
Profit after tax | Rs m | 127 | 141 | 155 | 82 | 81 | -413 | 144 | 136 | |
Gross profit margin | % | 12.6 | 16.6 | 17.1 | 17.7 | 15.8 | -57.4 | 30.0 | 25.2 | |
Effective tax rate | % | 15.4 | 15.0 | 17.1 | 21.8 | 26.8 | -4.9 | 7.9 | 4.8 | |
Net profit margin | % | 14.3 | 17.1 | 17.9 | 9.5 | 10.0 | -62.7 | 26.4 | 22.4 | |
Diluted EPS | Rs | 11.5 | 12.8 | 14.0 | 7.5 | 7.3 | -37.4 | 13.1 | 12.3 | |
Diluted EPS (TTM) | Rs | 43.2 | 46.3 | 49.4 | 45.8 | 41.6 | -8.6 | -9.6 | -4.7 | |
Subscriber Feature |
Asian share markets made a cautious start on Monday in a week where inflation figures could make or break hopes for earlier US rate cuts.